Salivary glands: A new player in phosphorus metabolism

Journal of Renal Nutrition

Volumn 21, Issue 1, 2011, Pages 39-42

  Savica, Vincenzo ^a   Calò, Lorenzo A ^b   Santoro, Domenico ^a   Monardo, Paolo ^a   Santoro, Giuseppe ^a   Muraca, Ugo ^a   Davis, Paul A ^c   Bellinghieri, Guido ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; PHOSPHORUS;

BLOOD; CHEWING GUM; CHRONIC KIDNEY FAILURE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERPHOSPHATEMIA; METABOLISM; RENAL REPLACEMENT THERAPY; REVIEW; SALIVA; SALIVARY GLAND;

CHEWING GUM; CHITOSAN; GLOMERULAR FILTRATION RATE; HUMANS; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; PHOSPHORUS; RENAL DIALYSIS; SALIVA; SALIVARY GLANDS;

EID: 78650707907     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2010.11.007     Document Type: Review

References (16)

1. Goldsmith D., Ritz E., Covic A. Vascular calcification: a stiff challenge for the nephrologists. Kidney Int 2004, 66:1315-1333.
2. Ganesh S.K., Stack A.G., Levin N.W., et al. Association of elevated serum PO4, CaxPO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001, 12:2131-2138.
3. Goodman W.G., Goldin J., Kuizon B.D., et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000, 342:1478-1483.
4. Guérin A.P., London G.M., Marchais S.J., et al. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000, 15:1014-1021.
5. Foley N.R., Collins A.J., Herzog C.A., et al. Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 2009, 20:397-404.
6. Li X.L., Yang H.Y., Giachelli C.M. Role of sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 2006, 98:905-912.
7. Eknoyan G., Levin A., Levin N.W. Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003, 42(Suppl 3). National Kidney Foundation, S1-S201.
8. Savica V., Calò L.A., Monardo P., et al. Phosphate binders and management of hyperphosphatemia in end stage renal disease. Nephrol Dial Transplant 2006, 21:2065-2068.
9. Young E.W., Akiba T., Albert J.M., et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcome and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004, 44:34-38.
10. Lac G. Saliva assays in clinical and research biology. Pathol Biol 2001, 49:660-667.
11. Savica V., Calò L.A., Caldarera R., et al. Phosphate salivary secretion in hemodialysis patients: implications for the treatment of hyperphosphatemia. Nephron Physiol 2007, 105:52-55.
12. Savica V., Calò L.A., Granata A., et al. A new approach to the evaluation of hyperphosphatemia in chronic kidney disease. Clin Nephrol 2007, 68:216-221.
13. Wright R.D., Blair-West J.R., Nelson J.F., et al. Handling of phosphate by a parotid gland (ovine). Am J Physiol. Renal Physiol 1984, 246:F916-F926. (6 pt 2).
14. Savica V., Calò L.A., Monardo P., et al. Salivary phosphate-binding chewing gum reduces hyperphosphatemia in dialysis patients. J Am Soc Nephrol 2009, 20:639-644.
15. Uribarri J. Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial 2007, 20:295-301.
16. Savica V., Calò L.A., Monardo P., et al. High phosphate content beverages in dialysis patients: relevance for hyperphosphatemia and cardiovascular risk. Nutr Metab Cardiovasc Dis 2008, 18:e39-e40.